Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Alpha-1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/19/2021 3 0
Pralatrexate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/17/2021 2 0
Excel (.xslx) CSV (.csv)